Chemistry, Chemical Biology & Biomedical Engineering

Androgen Receptor Antagonists: Lead Optimization and Preclinical Pharmacology

December 9, 2009

Androgen Receptor Antagonists: Lead Optimization and Preclinical PharmacologyAshvin V. Gavai, Ph.D. Bristol-Myers Squibb Oncology Chemistry Princeton, NJBabbio 321, 2:00 P.M. [Read more...]

Breakthrough Nanofiber Technology for Water Purification

December 2, 2009

Ben Chu, Ph.D. Department of Chemistry Stony Brook, NY Babbio 321, 2:00 P.M. [Read more...]

Shaping Nanostructures from the Bottom up with Block Copolymers

November 11, 2009

Shaping Nanostructures from the Bottom up with Block Copolymers Robert B. Grubbs, Ph.D. Associate Professor, Department of Chemistry, Stony Brook University, NYBabbio 321, 2:00 P.M. [Read more...]

Stimuli-Responsive Nanostructured Materials

November 4, 2009

Stimuli-Responsive Nanostructured Materials Sergiy Minko, Ph.D., Department of Chemistry & Biomolecular Science Clarkson University, Potsdam, NY Babbio 321, 2:00 P.M. [Read more...]

Technosphere(R) Insulin: Defining the Role of Technosphere Particles at the Cellular Level

October 28, 2009

Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular LevelRobert Angelo, Ph.D. Associate Director of Formulation Development and Cell Based Studies MannKind Corporation Danbury, CTBabbio 321, 2:00 P.M. [Read more...]

Yan-Hui Liu, Ph.D. Schering-Plough Research Institute

October 14, 2009

Application of Biological Mass Spectrometry in the Pharmaceutical Industry: Characterization of proteins as drug targets or therapeuticsYan-Hui Liu, Ph.D. Schering-Plough Research Institute, Kenilworth, NJBabbio 321, 2:00 P.M. [Read more...]

Covalent Capture of Kinase-specific Phosphopeptides Reveals Cdk1-cyclin B Substrates

October 7, 2009

Covalent Capture of Kinase-specific Phosphopeptides Reveals Cdk1-cyclin B SubstratesJustin D. Blethrow, Ph.D. Strategic Marketing Specialist, Thermo Fisher Scientific San Jose, CA Babbio 321, 2:00 P.M. [Read more...]

Use of High-Resolution Mass Spectrometry for Drug Metabolite Profiling and Identification

September 23, 2009

Use of High-Resolution Mass Spectrometry for Drug Metabolite Profiling and IdentificationMingshe Zhu, Ph.D. Biotransformation, Bristol-Myer Squibb Research and DevelopmentBabbio 321, 2:00 P.M. [Read more...]

Fundamentals of Intellectual Property

September 16, 2009

A Case Study of How to Take a University Invention from the Bench to a Commercialized ProductBeverly W. Lubit, Ph.D.Greenberg Traurig Law FirmBabbio 321, 2:00 P.M. [Read more...]

Regulation of Biofilm Development by Pseudomonas aeruginosa

April 15, 2009

Prof. Karin Sauer, SUNY Binghamton, Babbio 321, 2:00pm - 3:00pm [Read more...]

Molecular Epidemiology of S. aureus Infection

April 1, 2009

Dr. Barry Kreiswirth, PHRI UMDNJ, 2-3 PM Babbio 321 [Read more...]

Computer-Aided Drug Discovery of Novel Anti-Cancer Agents

February 20, 2009

Zoe Cournia, Department of Chemistry, Yale University [Read more...]

The Science and Technology of Orthopedic Implants

February 4, 2009

Dr. Marc Long, Stryker Orthopaedics, Mahwah, New Jersey [Read more...]

TBD

April 23, 2008

Students’ Seminars [Read more...]

Nucleoporin-Tpr Functions in Nuclear Transport and Beyond

April 16, 2008

Dr. Hualin ZhongAssistant ProfessorDepartment of Biological Sciences, Hunter CollegeHostJoe Glavy [Read more...]

Mechanotransduction in Bone Adaptation

April 9, 2008

Yi-Xian QinProfessor, Department of Biomedical EngineeringOrthopaedic Biomechanics and Instrumentation LaboratorySUNY Stony Brook [Read more...]

The use of cation-pi interactions to determine selectivity in modified schmidt reactions

April 2, 2008

Jennifer PoutsmaAssociate Professor & Graduate Program DirectorDepartment of Chemistry & BiochemistryOld Dominion University [Read more...]

Bioconjugated nanoparticles for bioanalysis and biotechnology

March 26, 2008

Weihong TanUniversity of Florida [Read more...]

P518 - A Novel Peptide Hormone Implicated in Osteoporosis

March 12, 2008

Dr. Nicholas MurgoloFellow, Discovery Technologies/BioinformaticsSchering-Plough Research Institute [Read more...]

Discovery of Januvia™ (sitagliptin), a Selective Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes

March 5, 2008

Ann E. Weber, PhDExecutive Director, Medicinal ChemistryMerck Research Laboratorie [Read more...]